All
FDA reports pros, cons of experimental shingles vaccine
January 3rd 2006Washington -- The Food and Drug Administration (FDA) reported recently that Zostavax, Merck & Co.?s experimental vaccine to prevent shingles, does help curb related pain but does not significantly affect rates of death or hospitalization, U.S. regulatory staff said in documents released recently.
Dermatologist reveals true identity of head lice treatment
January 3rd 2006Menlo Park, Calif. -- After an unsuccessful attempt to persuade pharmaceutical companies to fund further research on a head lice treatment he says he discovered and developed, a dermatologist here has revealed that the treatment is actually an over-the-counter skin cleanser.
Lay the groundwork for a financially stable retirement
January 1st 2006I'm not a big fan of New Year's resolutions. Before the first month of the new year rolls to a close, most will already be little more than hazy memories. Still, the beginning of a new year is a good time to reflect on the year just past, and take stock of your personal financial goals for the future — where you're heading, how you'll get there.
Lay the groundwork for a financially stable retirement
January 1st 2006I'm not a big fan of New Year's resolutions. Before the first month of the new year rolls to a close, most will already be little more than hazy memories. Still, the beginning of a new year is a good time to reflect on the year just past, and take stock of your personal financial goals for the future — where you're heading, how you'll get there.
Concerns about drug efficacy, safety surround mesotherapy
January 1st 2006Atlanta — Mesotherapy, a method of delivering drugs or mixtures subcutaneously, has been used in Europe for more than 50 years and in the United States for about five. According to one physician, there are reasons that mesotherapy has gained less-than-rave reviews domestically.
Elements underlying beauty provide guide for surgeons
January 1st 2006Baltimore — While there is general agreement that certain features define female facial beauty, it is often some idiosyncrasy that distinguishes exquisite beauty from ordinary attractiveness, according to Murad Alam, M.D., speaking at the East Coast Dermatology Seminar, here.
Detecting fungal disease first step in careful treatment
January 1st 2006If fingernails are abnormal but toenails are normal, the diagnosis is not likely to be onychomycosis. An exception to this rule, however, is in cases of Candida onycholysis, which are more common in women and among those with Raynaud's syndrome.
FDA, European agencies extend confidentiality arrangements
December 6th 2005Washington--The Food and Drug Administration (FDA), the European Commission (EU) and the European Medicines Agency (EMA) have agreed to a five-year extension of their confidentiality arrangements regarding medicines for human and veterinary use.
Antares partners with derm firm to adapt delivery platform
December 6th 2005Exton, Pa.--Antares Pharma and a firm specializing in treatments for dermatological conditions have signed a feasibility development agreement to develop and apply Antares' transdermal delivery ATD? gel platform to formulate an active compound contained in a topical skin product.
Counterfeit drug trade draws congressional scrutiny
December 1st 2005Counterfeit prescription drugs pose a "potentially serious health threat" in the United States — one that can result in serious or deadly consequences for patients because of unscrupulous acts of profiteers who take advantage of a lack of uniform regulation and enforcement.
Surgeon screens potential face transplant recipients
December 1st 2005Cleveland - With 20 years' experience in working withcomposite tissue allograft transplants, Maria Siemionow, M.D.,Ph.D., tells Dermatology Times she has laid the groundwork for whatlikely will be the world's first human face transplant.
Counterfeit drug trade draws congressional scrutiny
December 1st 2005Counterfeit prescription drugs pose a "potentially serious health threat" in the United States — one that can result in serious or deadly consequences for patients because of unscrupulous acts of profiteers who take advantage of a lack of uniform regulation and enforcement.
Using biologics to treat psoriasis
December 1st 2005Las Vegas — As dermatologists continue to incorporate biologics into their treatment approaches, Alan Menter, M.D., of Baylor University Medical Center, Dallas, and president of the International Psoriasis Council, discusses the efficacy and safety of five currently available biologic agents and the importance of transitioning patients onto these drugs without flare.